Bruker Corporation  

(Public, NASDAQ:BRKR)   Watch this stock  
Find more results for BRKR
28.20
-0.29 (-1.02%)
After Hours: 28.22 +0.02 (0.09%)
Jul 26, 4:10PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 28.05 - 28.54
52 week 19.58 - 30.02
Open 28.45
Vol / Avg. 402,890.00/725,492.00
Mkt cap 4.45B
P/E 29.96
Div/yield 0.04/0.57
EPS 0.94
Shares 159.94M
Beta 1.10
Inst. own 67%
Aug 3, 2017
Q2 2017 Bruker Corp Earnings Call - 4:45PM EDT - Add to calendar
Aug 3, 2017
Q2 2017 Bruker Corp Earnings Release - 4:00PM EDT - Add to calendar
Jun 14, 2017
Bruker Corp at Goldman Sachs Global Healthcare Conference
Jun 13, 2017
Bruker Corp at William Blair Growth Stock Conference
Jun 8, 2017
Bruker Corp at Jefferies Healthcare Conference - Webcast
May 22, 2017
Bruker Corp Annual Shareholders Meeting
May 4, 2017
Bruker Corp at Deutsche Bank Health Care Conference - Webcast
May 3, 2017
Q1 2017 Bruker Corp Earnings Call - Webcast
May 3, 2017
Q1 2017 Bruker Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '17) 2016
Net profit margin 5.64% 9.59%
Operating margin 9.77% 11.57%
EBITD margin - 15.97%
Return on average assets 4.77% 8.73%
Return on average equity 12.28% 21.75%
Employees 6,000 -
CDP Score - -

Address

40 MANNING RD
BILLERICA, MA 01821
United States - Map
+1-978-6633660 (Phone)
+1-978-6635585 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. The Bruker BioSpin Group segment designs, manufactures and distributes enabling life science tools. The Bruker CALID segment designs, manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as chemical, biological, radiological, nuclear and explosive detection products. The Bruker Nano segment designs, manufactures and distributes spectroscopy and microscopy instruments. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices. It also focuses on nanomechanical testing instruments.

Officers and directors

Frank H. Laukien Ph.D. Chairman of the Board, President, Chief Executive Officer
Age: 57
Bio & Compensation  - Reuters
Anthony L. Mattacchione Chief Financial Officer, Senior Vice President
Age: 54
Bio & Compensation  - Reuters
Juergen Srega President of Bruker CALID Group and Bruker Daltonics Division
Age: 62
Bio & Compensation  - Reuters
Mark Robert Munch Ph.D. Executive Vice President - President of Bruker Nano Group and Bruker Nano Surfaces Division
Age: 55
Bio & Compensation  - Reuters
William A. Linton Lead Independent Director
Age: 69
Bio & Compensation  - Reuters
Joerg C. Laukien Director
Age: 63
Bio & Compensation  - Reuters
Cynthia M. Friend Ph.D. Independent Director
Age: 62
Bio & Compensation  - Reuters
Marc A. Kastner Ph.D. Independent Director
Age: 71
Bio & Compensation  - Reuters
Richard D. Kniss Independent Director
Age: 76
Bio & Compensation  - Reuters